drugset / Trial / NCT00387556

Ondansetron Reduce Vomiting Associated With Ketamine PSA

NCT00387556

Completed 268 enrolled University of Colorado, Denver
RandomizedParallel-groupTriple-blindTreatment

Summary

Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.

Timeline

Start
2002-12
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 0.15 mg/kg

Indications

No indication recorded.